Partnering to Achieve Epidemic Control in Mozambique

 Description: Mozambique PEPFAR logo - Mozambicans and Americans in Partnership to Fight HIV/AIDS

Get Acrobat Reader PDF Version

The United States is proud to support Mozambique’s leadership in the global HIV/AIDS response. PEPFAR provides service delivery and technical assistance in Mozambique to maximize the quality, coverage, and impact of the national HIV/AIDS response.

Working together with the Government of Mozambique, PEPFAR is aligning investments to scale up evidence-based interventions in the geographic areas and populations with the highest burden of HIV/AIDS–in line with PEPFAR 3.0.1 Mozambique is participating in the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a two-year effort to enable 300,000 more children living with HIV/AIDS to receive life-saving antiretroviral treatment across priority countries in sub-Saharan Africa. Specific priorities include

  • Expanding treatment services and increasing quality of care to improve treatment outcomes
  • Scaling up HIV prevention services including voluntary medical male circumcision (VMMC) and prevention of mother-to-child HIV transmission (PMTCT) by supporting Option B+
  • Strengthening the health and social welfare system, including community structures to support orphans and vulnerable children and services targeting gender-based violence
  • Implementing cross-cutting activities for HIV/AIDS-related surveillance, including implementing more strategic monitoring and evaluation across programs and strengthening national health information systems to improve management and use of data
  • Supporting service-delivery platforms by procuring HIV commodities and providing technical assistance to strengthen supply chain management


HIV/AIDS in Mozambique

Number of people living with HIV (all ages), 20142

1,500,000

Deaths due to AIDS (all ages), 20142

45,000

Number of orphans due to AIDS (0-17), 20142   

610,000

Estimated antiretroviral treatment coverage (adults ages 15+), 20143

42%

Estimated percentage of pregnant women living with HIV who receive antiretorviral medications for PMTCT, 20143

91%


Saving Lives

In 2015, PEPFAR supported the following achievements in Mozambique:

  • Life-saving antiretroviral treatment for 668,078 people
  • VMMC for HIV prevention for 187,186 men
  • Testing and counseling for over 5.7 million people
  • Care and support for 254,924 orphans and vulnerable children affected by HIV/AIDS
  • Antiretroviral medications for 94,039 pregnant women living with HIV to reduce mother-to-child transmission

Get the most up-to-date data on program results, expenditures, and planned funding at Data.pepfar.net.

PEPFAR Planned Funding in Mozambique, 2004-2015 (USD in Millions)4

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

$39

$59

$94

$162

$229

$226

$269

$269

$231

$262

$277

$331


1. Office of the U.S. Global AIDS Coordinator and Health Diplomacy. (2014). PEPFAR 3.0 - Controlling the epidemic: Delivering on the promise of an AIDS-free generation. Washington, DC: Author.

2. UNAIDS. (2014). Mozambique: HIV and AIDS estimates. Retrieved August 12, 2015, from http://www.unaids.org/en/regionscountries/countries/mozambique/

3. UNAIDS. (2015). How AIDS changed everything. Geneva: Author.

4. Data reflect information available on the PEPFAR Dashboards and PEPFAR.gov, which represent planned new bilateral funding initially approved in the PEPFAR Country Operational Plans/Regional Operational Plans (COPs/ROPs) each fiscal year. As additional funding may be approved and made available after the initial COPs/ROPs submission, or to PEPFAR-supported countries that are not required to submit an annual COP/ROP, data on the Dashboards may not represent the final PEPFAR programmatic funding level in countries each fiscal year.


USA.gov U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA